Top Media Providers

Citizens reiterates CRISPR Therapeutics stock rating on Casgevy sales

Investing.comBy Investing.com

11/3/2026, 9:32:46 AM

EXECUTIVE SUMMARY

Citizens reiterates CRISPR Therapeutics stock rating on Casgevy sales....

Published originally on Investing.com

Finance & Markets20m ago

BMO upgrades Marsh stock rating on large-employer focus....

Investing.com

Finance & Markets20m ago

BMO downgrades Arthur J. Gallagher stock rating on valuation....

Investing.com

Finance & Markets20m ago

Raymond James reiterates Airbnb stock rating on AI tailwinds....

Investing.com

Finance & Markets21m ago

Goldman Sachs reiterates Neutral on Moderna stock, $137 target ahead of earnings....

Investing.com

Multikhabar App

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!